Industrial animal agriculture has relied extensively on the use of an antibiotic unused in human medicine, but new research ...

Blacksmith Medicines, Inc. (Blacksmith), a leading biopharma dedicated to discovering and developing therapeutics targeting metalloenzymes, today announced that the United States Patent and Trademark ...

Wockhardt is advancing Zaynich, a novel antibiotic combination, targeting drug-resistant infections, with plans for ...

Iterum Therapeutics plc (Nasdaq: ITRM) (the “Company” or “Iterum”), a company focused on delivering next generation oral and IV antibiotics to treat infections caused by multi-drug resistant pathogens ...

Findings show imported seafood as a potential source of colistin-resistance genes, underscoring the urgency of addressing ...

A new study by researchers from the University of Georgia has uncovered a troubling pathway for the spread of antibiotic ...

Everest Medicines (HKEX 1952.HK, 'Everest', or the 'Company'), a biopharmaceutical company focused on the discovery, clinical development, manufacturing, and commercialization of innovative ...

A team of US researchers on Sunday said it has identified a way that colistin (a potent, last-resort antibiotic) resistance ...

Colistin is a potent, last-resort antibiotic used only to treat people with dangerous, life-threatening bacterial infections ...

Iterum Therapeutics plc (Nasdaq: ITRM) ("Iterum" or the "Company"), a company committed to delivering next generation oral and IV antibiotics to ...

Scientists discovered a key protein, MigC, that helps a dangerous superbug, *A. baumannii*, build its protective outer layer ...